Cancer incidence and glucose lowering therapies for Type 2 Diabetes: Are there differences between agents?

2 型糖尿病的癌症发病率和降糖疗法：药物之间是否存在差异？

• 批准号: 211818
• 负责人: Johnson Jeffrey A
• 金额: $ 9.86万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2010
• 资助国家: 加拿大
• 起止时间: 2010-09-01 至 2012-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=211818&lang=en
• 关键词: Cancer; Epidemiology; Insulin; Metabolic Syndrome; Oral Hypoglycemic Agents; Type 2 Diabetes

Diabetes and cancer are two conditions affecting more and more Canadians. They share many risk factors, including diet, physical inactivity, smoking and obesity. It is not surprising then that people with diabetes have a higher risk of many types of can

糖尿病和癌症是影响越来越多加拿大人的两种疾病。 他们有许多共同的风险因素，包括饮食、缺乏运动、吸烟和肥胖。 因此，糖尿病患者患多种癌症的风险更高也就不足为奇了。